Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001410939-20-000017
Filing Date
2020-04-28
Accepted
2020-04-28 16:22:57
Documents
7
Period of Report
2020-04-28
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxystatementfor2020annua.htm DEF 14A 1134454
2 a0396ddivericbiocommon042720.jpg GRAPHIC 750102
3 atriskpay.jpg GRAPHIC 135079
4 drgsignaturea02.gif GRAPHIC 2991
5 ivericbio2a01.jpg GRAPHIC 142773
6 realizablepaya02.jpg GRAPHIC 56917
7 vericbiocommon042720a02.jpg GRAPHIC 352962
  Complete submission text file 0001410939-20-000017.txt   3119445
Mailing Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119
Business Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

EIN.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36080 | Film No.: 20825353
SIC: 2834 Pharmaceutical Preparations